STOCK TITAN
  1. Home
  2. Sec-filings
  3. RVMD
  4. [Form 4] Revolution Medicines, Inc. Insider Trading Activity

Revolution Medicines (RVMD) CEO trades stock under preset 10b5-1 plan

Filing Impact
(Very High)
Filing Sentiment
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

Revolution Medicines, Inc. (RVMD) reported that President and Chief Executive Officer Mark A. Goldsmith exercised options for 80,000 shares of common stock at an exercise price of $4.73 per share and, on the same date, sold an aggregate of 86,000 shares of common stock in multiple transactions at weighted average prices between $206.78 and $212.74, including sales through revocable trusts. The filing notes that these transactions were made pursuant to a Rule 10b5-1 trading plan adopted on May 22, 2026, and that his reported holdings include 182,938 restricted stock units.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider GOLDSMITH MARK A
Role See Remarks
Sold 86,000 shs ($17.99M)
Approx. gross sale proceeds $17.99M
Approx. exercise cost $378K
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) F1 80,000 $0.00 $0.00
Exercise Common Stock F1, F2 80,000 $4.73 $378K
Sale Common Stock F1, F3, F2 5,128 $207.233 $1.06M
Sale Common Stock F1, F4, F2 24,917 $208.3697 $5.19M
Sale Common Stock F1, F5, F2 35,938 $209.2615 $7.52M
Sale Common Stock F1, F6, F2 3,813 $210.2466 $802K
Sale Common Stock F1, F7, F2 6,583 $211.3331 $1.39M
Sale Common Stock F1, F8, F2 3,621 $212.0776 $768K
Sale Common Stock F9, F10 190 $207.2454 $39K
Sale Common Stock F11, F10 951 $208.3648 $198K
Sale Common Stock F12, F10 1,351 $209.2812 $283K
Sale Common Stock F13, F10 136 $210.4017 $29K
Sale Common Stock F14, F10 245 $211.4651 $52K
Sale Common Stock F15, F10 127 $212.0635 $27K
Sale Common Stock F9, F16 177 $207.2515 $37K
Sale Common Stock F17, F16 937 $208.3609 $195K
Sale Common Stock F18, F16 1,405 $209.2664 $294K
Sale Common Stock F13, F16 126 $210.403 $27K
Sale Common Stock F14, F16 229 $211.4648 $48K
Sale Common Stock F15, F16 126 $212.0641 $27K
holding Common Stock F19 -- -- --
Holdings After Transaction: Stock Option (Right to Buy) — 344,085 shares (Direct); Common Stock — 267,330 shares (Direct); Common Stock — 655,484 shares (Indirect, Trust)
Footnotes (19)
  1. F1. Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on May 22, 2026.
  2. F2. Includes 182,938 restricted stock units.
  3. F3. This transaction was executed in multiple trades at prices ranging from $206.78 to $207.7750. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. F4. This transaction was executed in multiple trades at prices ranging from $207.79 to $208.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. F5. This transaction was executed in multiple trades at prices ranging from $208.80 to $209.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  6. F6. This transaction was executed in multiple trades at prices ranging from $209.80 to $210.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  7. F7. This transaction was executed in multiple trades at prices ranging from $210.81 to $211.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  8. F8. This transaction was executed in multiple trades at prices ranging from $211.82 to $212.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  9. F9. This transaction was executed in multiple trades at prices ranging from $206.78 to $207.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  10. F10. Held by Jonathan Goldsmith Revocable Trust.
  11. F11. This transaction was executed in multiple trades at prices ranging from $207.84 to $208.82. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  12. F12. This transaction was executed in multiple trades at prices ranging from $208.84 to $209.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  13. F13. This transaction was executed in multiple trades at prices ranging from $209.87 to $210.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  14. F14. This transaction was executed in multiple trades at prices ranging from $210.93 to $211.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  15. F15. This transaction was executed in multiple trades at prices ranging from $212.00 to $212.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  16. F16. Held by Rebecca Goldsmith Revocable Trust.
  17. F17. This transaction was executed in multiple trades at prices ranging from $207.80 to $208.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  18. F18. This transaction was executed in multiple trades at prices ranging from $208.80 to $209.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  19. F19. Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.
Options exercised 80,000 shares Stock option exercise into common stock on August 21, 2026
Option exercise price $4.73 per share Exercise price for 80,000-share stock option
Shares sold 86,000 shares Aggregate common stock sold in reported transactions
Sale price range $206.78–$212.74 per share Ranges for weighted average prices in multiple sale trades
Restricted stock units 182,938 units RSUs included in CEO’s reported holdings
Options remaining after exercise 344,085 options Total derivative securities following the option transaction
Net shares sold 86,000 shares Net buy/sell shares in transaction summary (net-sell)
Rule 10b5-1 plan adoption date May 22, 2026 Adoption date of trading plan governing these transactions
Rule 10b5-1 trading plan regulatory
"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
restricted stock units financial
"Includes 182,938 restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
weighted average price financial
"The price reported above reflects the weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
revocable trust financial
"Held by Jonathan Goldsmith Revocable Trust."
A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.
Stock Option (Right to Buy) financial
"security_title": "Stock Option (Right to Buy)"

FAQ

What insider transactions did RVMD CEO Mark A. Goldsmith report on August 21, 2026?
Mark A. Goldsmith reported exercising options for 80,000 shares of Revolution Medicines common stock at $4.73 per share and selling an aggregate of 86,000 shares of common stock in multiple transactions at weighted average prices between $206.78 and $212.74.

Were the recent RVMD insider sales by the CEO made under a Rule 10b5-1 plan?
Yes. The transactions are described as made pursuant to a Rule 10b5-1 trading plan adopted by Mark A. Goldsmith on May 22, 2026, indicating the trades were pre-arranged under that plan.

How many RVMD shares did the CEO sell in the reported Form 4 filing?
The CEO reported selling an aggregate of 86,000 shares of Revolution Medicines common stock across multiple transactions, including direct holdings and shares held through revocable trusts.

What option exercise did the RVMD CEO report in this Form 4?
He reported exercising a stock option for 80,000 shares of Revolution Medicines common stock at an exercise price of $4.73 per share. The option had an original exercise date of August 9, 2023 and an expiration date of August 8, 2029.

At what prices were the RVMD CEO’s sales executed in this filing?
The reported common stock sales were executed at weighted average prices ranging from about $206.78 to $212.74 per share, with individual trades within specified price ranges described in the footnotes.

What portion of the RVMD CEO’s reported holdings consists of restricted stock units?
A footnote states that the CEO’s reported holdings include 182,938 restricted stock units, which are part of his overall reported equity position.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
GOLDSMITH MARK A
(Last)(First)(Middle)
C/O REVOLUTION MEDICINES, INC.
700 SAGINAW DRIVE
(Street)
REDWOOD CITY CALIFORNIA 94063
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Revolution Medicines, Inc. [ RVMD ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
See Remarks
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/21/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/21/2026M(1)80,000A$4.73347,330(2)D
Common Stock08/21/2026S(1)5,128D$207.233(3)342,202(2)D
Common Stock08/21/2026S(1)24,917D$208.3697(4)317,285(2)D
Common Stock08/21/2026S(1)35,938D$209.2615(5)281,347(2)D
Common Stock08/21/2026S(1)3,813D$210.2466(6)277,534(2)D
Common Stock08/21/2026S(1)6,583D$211.3331(7)270,951(2)D
Common Stock08/21/2026S(1)3,621D$212.0776(8)267,330(2)D
Common Stock08/21/2026S190D$207.2454(9)64,234ITrust(10)
Common Stock08/21/2026S951D$208.3648(11)63,283ITrust(10)
Common Stock08/21/2026S1,351D$209.2812(12)61,932ITrust(10)
Common Stock08/21/2026S136D$210.4017(13)61,796ITrust(10)
Common Stock08/21/2026S245D$211.4651(14)61,551ITrust(10)
Common Stock08/21/2026S127D$212.0635(15)61,424ITrust(10)
Common Stock08/21/2026S177D$207.2515(9)64,247ITrust(16)
Common Stock08/21/2026S937D$208.3609(17)63,310ITrust(16)
Common Stock08/21/2026S1,405D$209.2664(18)61,905ITrust(16)
Common Stock08/21/2026S126D$210.403(13)61,779ITrust(16)
Common Stock08/21/2026S229D$211.4648(14)61,550ITrust(16)
Common Stock08/21/2026S126D$212.0641(15)61,424ITrust(16)
Common Stock594,060ITrust(19)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$4.7308/21/2026M(1)80,00008/09/202308/08/2029Common Stock80,000$0344,085D
Explanation of Responses:
1. Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on May 22, 2026.
2. Includes 182,938 restricted stock units.
3. This transaction was executed in multiple trades at prices ranging from $206.78 to $207.7750. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
4. This transaction was executed in multiple trades at prices ranging from $207.79 to $208.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
5. This transaction was executed in multiple trades at prices ranging from $208.80 to $209.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
6. This transaction was executed in multiple trades at prices ranging from $209.80 to $210.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
7. This transaction was executed in multiple trades at prices ranging from $210.81 to $211.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
8. This transaction was executed in multiple trades at prices ranging from $211.82 to $212.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
9. This transaction was executed in multiple trades at prices ranging from $206.78 to $207.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
10. Held by Jonathan Goldsmith Revocable Trust.
11. This transaction was executed in multiple trades at prices ranging from $207.84 to $208.82. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
12. This transaction was executed in multiple trades at prices ranging from $208.84 to $209.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
13. This transaction was executed in multiple trades at prices ranging from $209.87 to $210.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
14. This transaction was executed in multiple trades at prices ranging from $210.93 to $211.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
15. This transaction was executed in multiple trades at prices ranging from $212.00 to $212.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
16. Held by Rebecca Goldsmith Revocable Trust.
17. This transaction was executed in multiple trades at prices ranging from $207.80 to $208.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
18. This transaction was executed in multiple trades at prices ranging from $208.80 to $209.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
19. Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.
Remarks:
President and Chief Executive Officer
/s/ Jack Anders, as attorney-in fact for Mark A. Goldsmith08/25/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR